Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 18;36(26):3868-3875.
doi: 10.1016/j.vaccine.2018.02.043. Epub 2018 May 16.

Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center

Kaan Z Apaydin  1 , Holly B Fontenot  2 , Derri Shtasel  3 , Sannisha K Dale  4 , Christina P C Borba  5 , Christopher S Lathan  6 , Lori Panther  1 , Kenneth H Mayer  7 , Alex S Keuroghlian  8
Affiliations

Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center

Kaan Z Apaydin et al. Vaccine. .

Abstract

Background: Young sexual minority individuals have lower human papillomavirus (HPV) vaccine completion rates than the general population, and little is known about how gender minority people perceive HPV vaccination. The aim of this study was to qualitatively identify patient-, provider-, and systems-level barriers and facilitators for HPV vaccination among sexual and gender minority (SGM) people.

Methods: Fifteen SGM-identified individuals, ages 23-26, were recruited at an urban community health center in Boston, MA, that specializes in care for SGM. Participants were enrolled in a study that utilized surveys and in-person focus groups. During focus groups, participants were asked to describe their perceived barriers and facilitators for completion of HPV vaccination.

Results: Fourteen participants reported having a sexual minority identity, and five participants reported having a gender minority identity. Participants described the following factors influencing HPV vaccination: (1) at the patient level, low HPV-related knowledge and lack of engagement in care were associated with less vaccination, whereas fear of HPV-related disease motivated vaccination; (2) at the provider level, knowledge and SGM cultural-competence related to HPV was associated with patient willingness to be vaccinated; (3) at the systems level, SGM identity-affirming healthcare settings were associated with increased vaccination, whereas historical trends in HPV vaccine marketing selectively for cisgender women and lack of public awareness of HPV-related disease among SGM were associated with decreased vaccincation.

Conclusion: Our study identified internal and external barriers for HPV vaccination related among SGM patients. These findings highlight the need to increase public awareness about the risks of HPV-related disease among SGM and educate SGM youth about HPV-related disease and vaccine importance. Finally, this study supports the need for future interventions to cultivate SGM-competent providers and SGM identity-affirming healthcare settings as a way to increase HPV vaccination.

Keywords: HPV; HPV-related cancers; Human papillomavirus; Sexual and gender minority; Transgender; Vaccine.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests

The authors have no conflicts of interest to report.

References

    1. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MCB, et al. Sexually transmitted infections among US women and men. Sex Transm Dis 2013;40:187–93. 10.1097/OLQ.0b013e318286bb53. - DOI - PubMed
    1. Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, et al. US assessment of HPV types in cancers: Implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 2015;107 10.1093/jnci/djv086. - DOI - PMC - PubMed
    1. Centers for disease control and prevention. How many cancers are linked with HPV each year? 2017. https://www.cdc.gov/cancer/hpv/statistics/cases.htm [accessed June 14, 2017].
    1. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination — updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2016;65:1405–8. https://doi.org/10.15585/mmwr.mm6549a5. - DOI - PubMed
    1. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2014;63:1–30. - PubMed

Publication types

Substances